Cargando…

Development of smart anti-glycan reagents using immunized lampreys

Studies on the expression of cellular glycans are limited by a lack of sensitive tools that can discriminate specific structural features. Here we describe the development of a robust platform using immunized lampreys (Petromyzon marinus), which secrete variable lymphocyte receptors called VLRBs as...

Descripción completa

Detalles Bibliográficos
Autores principales: McKitrick, Tanya R., Goth, Christoffer K., Rosenberg, Charles S., Nakahara, Hirotomo, Heimburg-Molinaro, Jamie, McQuillan, Alyssa M., Falco, Rosalia, Rivers, Nicholas J., Herrin, Brantley R., Cooper, Max D., Cummings, Richard D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048801/
https://www.ncbi.nlm.nih.gov/pubmed/32111965
http://dx.doi.org/10.1038/s42003-020-0819-2
_version_ 1783502337524891648
author McKitrick, Tanya R.
Goth, Christoffer K.
Rosenberg, Charles S.
Nakahara, Hirotomo
Heimburg-Molinaro, Jamie
McQuillan, Alyssa M.
Falco, Rosalia
Rivers, Nicholas J.
Herrin, Brantley R.
Cooper, Max D.
Cummings, Richard D.
author_facet McKitrick, Tanya R.
Goth, Christoffer K.
Rosenberg, Charles S.
Nakahara, Hirotomo
Heimburg-Molinaro, Jamie
McQuillan, Alyssa M.
Falco, Rosalia
Rivers, Nicholas J.
Herrin, Brantley R.
Cooper, Max D.
Cummings, Richard D.
author_sort McKitrick, Tanya R.
collection PubMed
description Studies on the expression of cellular glycans are limited by a lack of sensitive tools that can discriminate specific structural features. Here we describe the development of a robust platform using immunized lampreys (Petromyzon marinus), which secrete variable lymphocyte receptors called VLRBs as antibodies, for generating libraries of anti-glycan reagents. We identified a wide variety of glycan-specific VLRBs detectable in lamprey plasma after immunization with whole fixed cells, tissue homogenates, and human milk. The cDNAs from lamprey lymphocytes were cloned into yeast surface display (YSD) libraries for enrichment by multiple methods. We generated VLRB-Ig chimeras, termed smart anti-glycan reagents (SAGRs), whose specificities were defined by microarray analysis and immunohistochemistry. 15 VLRB antibodies were discovered that discriminated between linkages, functional groups and unique presentations of the terminal glycan motif. The development of SAGRs will enhance future studies on glycan expression by providing sequenced, defined antibodies for a variety of research applications.
format Online
Article
Text
id pubmed-7048801
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-70488012020-03-05 Development of smart anti-glycan reagents using immunized lampreys McKitrick, Tanya R. Goth, Christoffer K. Rosenberg, Charles S. Nakahara, Hirotomo Heimburg-Molinaro, Jamie McQuillan, Alyssa M. Falco, Rosalia Rivers, Nicholas J. Herrin, Brantley R. Cooper, Max D. Cummings, Richard D. Commun Biol Article Studies on the expression of cellular glycans are limited by a lack of sensitive tools that can discriminate specific structural features. Here we describe the development of a robust platform using immunized lampreys (Petromyzon marinus), which secrete variable lymphocyte receptors called VLRBs as antibodies, for generating libraries of anti-glycan reagents. We identified a wide variety of glycan-specific VLRBs detectable in lamprey plasma after immunization with whole fixed cells, tissue homogenates, and human milk. The cDNAs from lamprey lymphocytes were cloned into yeast surface display (YSD) libraries for enrichment by multiple methods. We generated VLRB-Ig chimeras, termed smart anti-glycan reagents (SAGRs), whose specificities were defined by microarray analysis and immunohistochemistry. 15 VLRB antibodies were discovered that discriminated between linkages, functional groups and unique presentations of the terminal glycan motif. The development of SAGRs will enhance future studies on glycan expression by providing sequenced, defined antibodies for a variety of research applications. Nature Publishing Group UK 2020-02-28 /pmc/articles/PMC7048801/ /pubmed/32111965 http://dx.doi.org/10.1038/s42003-020-0819-2 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
McKitrick, Tanya R.
Goth, Christoffer K.
Rosenberg, Charles S.
Nakahara, Hirotomo
Heimburg-Molinaro, Jamie
McQuillan, Alyssa M.
Falco, Rosalia
Rivers, Nicholas J.
Herrin, Brantley R.
Cooper, Max D.
Cummings, Richard D.
Development of smart anti-glycan reagents using immunized lampreys
title Development of smart anti-glycan reagents using immunized lampreys
title_full Development of smart anti-glycan reagents using immunized lampreys
title_fullStr Development of smart anti-glycan reagents using immunized lampreys
title_full_unstemmed Development of smart anti-glycan reagents using immunized lampreys
title_short Development of smart anti-glycan reagents using immunized lampreys
title_sort development of smart anti-glycan reagents using immunized lampreys
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048801/
https://www.ncbi.nlm.nih.gov/pubmed/32111965
http://dx.doi.org/10.1038/s42003-020-0819-2
work_keys_str_mv AT mckitricktanyar developmentofsmartantiglycanreagentsusingimmunizedlampreys
AT gothchristofferk developmentofsmartantiglycanreagentsusingimmunizedlampreys
AT rosenbergcharless developmentofsmartantiglycanreagentsusingimmunizedlampreys
AT nakaharahirotomo developmentofsmartantiglycanreagentsusingimmunizedlampreys
AT heimburgmolinarojamie developmentofsmartantiglycanreagentsusingimmunizedlampreys
AT mcquillanalyssam developmentofsmartantiglycanreagentsusingimmunizedlampreys
AT falcorosalia developmentofsmartantiglycanreagentsusingimmunizedlampreys
AT riversnicholasj developmentofsmartantiglycanreagentsusingimmunizedlampreys
AT herrinbrantleyr developmentofsmartantiglycanreagentsusingimmunizedlampreys
AT coopermaxd developmentofsmartantiglycanreagentsusingimmunizedlampreys
AT cummingsrichardd developmentofsmartantiglycanreagentsusingimmunizedlampreys